http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2482702-C2

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_daeda0750cb981dff763bf1e73fa2448
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A23L11-00
filingDate 2010-09-09-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2013-05-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a3de1758469a997b0627d8138edde070
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f16bc0d072e5b6a355a0a079dd5af75a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_84f707dae7b62ae6e837baa9427172c5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ecf066ebc79ce8d1270b9f949f9516c5
publicationDate 2013-05-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber RU-2482702-C2
titleOfInvention Protein-vitamin product manufacture method
abstract FIELD: food industry. n SUBSTANCE: invention relates to food industry and may be used during manufacture of protein food products of functional purpose using soya. The method involves soya protein base preparation, protein thermal-acid coagulation in the base by means of a lactic acid coagulating agent, protein clot separation from soya whey and the clot moulding. The protein thermal-acid coagulation in the soya protein base is performed using a mixture of milk whey and a 5%-ascorbic acid solution at a ratio of 1:1; the 5%- ascorbic acid solution is produced by way of dissolution in milk whey. The separated protein clot is conditioned till moisture content is equal to 10-80% and moulded to produce granules or paste or puree. One prepares protein-vitamin beverages based on the separated soya-and-milk whey by way of mixing with fruit or berry nectars or purees and subsequent homogenisation. n EFFECT: invention allows to manufacture a functional food product intended for systematic consumption for alimentation of all the age groups of healthy population, the product preserving and improving health due to physiologically functional ingredients presence in the product composition. n 1 ex
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2566449-C1
priorityDate 2010-09-09-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2252681-C1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2385630-C1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2218816-C2
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID3847
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID3847
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419507743
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID417109324
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID612
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID54670067

Total number of triples: 24.